GABARAPL1 and myocardial infarction: Furthermore, the most potential target drug PIK90, performed by drug prediction and molecular docking for GABARAPL1, significantly alleviated cardiac dysfunction and myocardial fibrosis induced by MI in mice, and it could inhibit hypoxia‐induced pyroptosis in endothelial cells.